Despite not knowing all of the functions performed by ITGA5, multiple studies have demonstrated that increased expression of ITGA5 is associated with poor prognosis in multiple tumors types, such as triple negative breast cancer [14], lung cancer [35], hepatocellular carcinoma [36] and ovarian cancer [37]. This evidence concerns the gene ITGA5 and triple-negative breast carcinoma.